Psychiatric Annals最新文献_第7页

The Use of Cannabinoids in Clinical Psychiatry 大麻素在临床精神病学中的应用

IF 0.5 4区医学

Psychiatric Annals Pub Date : 2023-06-01 DOI: 10.3928/00485713-20230519-01

José Diogo R. de Souza, José Alexandre S. Crippa

引用次数: 0

Prisons as a De Facto Mental Health System 监狱作为一个事实上的心理健康系统

IF 0.5 4区医学

Psychiatric Annals Pub Date : 2023-06-01 DOI: 10.3928/00485713-20230523-01

A. Nierenberg

引用次数: 0

Effects of Heat Treatment On Dysmenorrhea and Its Mental Health Outcomes: A Randomized Clinical Trial 热疗法治疗痛经及其心理健康效果的随机临床试验

IF 0.5 4区医学

Psychiatric Annals Pub Date : 2023-06-01 DOI: 10.3928/00485713-20230506-01

Hülya Türkmen, Selda Yörük

{"title":"Effects of Heat Treatment On Dysmenorrhea and Its Mental Health Outcomes: A Randomized Clinical Trial","authors":"Hülya Türkmen, Selda Yörük","doi":"10.3928/00485713-20230506-01","DOIUrl":"https://doi.org/10.3928/00485713-20230506-01","url":null,"abstract":"This randomized controlled prospective experimental trial was conducted with 46 students with dysmenorrhea who were randomized in a 1:1 ratio to the heat treatment group (HTG) (\u0000 n\u0000 = 23) and control group (CG) (\u0000 n\u0000 = 23). To HTG, dry heat was applied for 20 minutes to the lower abdominal region of the subjects when their dysmenorrhea was most severe. Visual Analogue Scale (VAS), the Short Form McGill Pain Questionnaire (SF-MPQ), the Menstrual Attitude Questionnaire (MAQ), and the Depression Anxiety and Stress Scale (DASS) were used in this study. At the first menstrual cycle, both groups received the questionnaires, and no treatment was applied. At the second, third, and fourth menstrual cycles, VAS and SF-MPQ were applied before the treatment (T1), right after the treatment (T2), and 2 hours after the treatment (T3). MAQ and DASS were applied right after the treatment. Seven subjects from HTG and four subjects from CG were excluded from the study on account of their analgesic medicine usage, inability to menstruate, or by their own requests. When HTG and CG were compared, the decrease in the dysmenorrhea pain after the heat treatment in each of the three menstrual cycles was found to be statistically significant (\u0000 P\u0000 < 0.05). In each of the four menstrual cycles, depression, anxiety, and stress were detected in each subject in both groups. However, the effectiveness of the treatment was not determined (\u0000 P\u0000 > 0.05). In HTG, awareness of the changes during menstruation was diminished with time.\u0000 \u0000 [\u0000 Psychiatr Ann\u0000 . 2023;53(6):270–281.]","PeriodicalId":20917,"journal":{"name":"Psychiatric Annals","volume":" ","pages":""},"PeriodicalIF":0.5,"publicationDate":"2023-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41716398","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Current Evidence of Cannabidiol's Potential as an Anxiolytic Agent 大麻二酚作为焦虑剂潜力的最新证据

IF 0.5 4区医学

Psychiatric Annals Pub Date : 2023-06-01 DOI: 10.3928/00485713-20230515-02

G. Rossi, J. C. A. Reis, J. Hallak, R. G. Santos

引用次数: 0

Psychiatric Manifestations of Modern Scurvy: A Case Series and Literature Review 现代坏血病的精神病学表现：病例系列及文献综述

IF 0.5 4区医学

Psychiatric Annals Pub Date : 2023-06-01 DOI: 10.3928/00485713-20230421-01

P. Jaini, Jamie K. Alexander, Sara Elchehabi, J. Briggs, Dustin S DeMoss, Cheryl L Hurd, A. J. Rush

{"title":"Psychiatric Manifestations of Modern Scurvy: A Case Series and Literature Review","authors":"P. Jaini, Jamie K. Alexander, Sara Elchehabi, J. Briggs, Dustin S DeMoss, Cheryl L Hurd, A. J. Rush","doi":"10.3928/00485713-20230421-01","DOIUrl":"https://doi.org/10.3928/00485713-20230421-01","url":null,"abstract":"\u0000 Scurvy is often considered to be a historical disease that once affected sailors, and so its modern-day prevalence is underestimated. Scurvy can present in various ways, such as with mucocutaneous and/or hematological symptoms in classic scurvy or with isolated psychiatric symptoms in neuropsychiatric scurvy. We describe two patient presentations of scurvy with borderline-low vitamin C levels and neuropsychiatric symptoms. Patient 1 presented with an exacerbation of major depressive symptoms and classic physical symptoms of scurvy, while Patient 2 presented with new-onset psychotic symptoms and no physical symptoms. Both patients had significant improvement of symptoms with vitamin C supplementation. We also conducted a literature search of MED-LINE via PubMed, identifying 16 cases of patients who met criteria for a scurvy diagnosis and presented with psychiatric symptoms that responded to vitamin C supplementation. The cases and literature review revealed that patients with scurvy can have variable psychiatric symptoms with or without the presence of mucocutaneous signs. Therefore, to optimize detection of suspected cases, diagnostic guidelines for scurvy should include psychiatric symptoms in addition to classic signs. Patients with acute psychiatric symptoms and a history of malnutrition should be screened for hypovitaminosis C. An empirical trial of vitamin C supplementation may also be of value in some cases when borderline-low vitamin C levels are found in suspected neuropsychiatric scurvy.\u0000 \u0000 [\u0000 Psychiatr Ann\u0000 . 2023;53(6):282–288.]\u0000 \u0000","PeriodicalId":20917,"journal":{"name":"Psychiatric Annals","volume":" ","pages":""},"PeriodicalIF":0.5,"publicationDate":"2023-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"47182383","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Therapeutic Profile of Cannabidiol in the Broad Symptomatology of Autism Spectrum Disorder: Evidence From Basic Science to Clinical Approaches 大麻二酚在自闭症谱系障碍广泛症状中的治疗概况：从基础科学到临床方法的证据

IF 0.5 4区医学

Psychiatric Annals Pub Date : 2023-06-01 DOI: 10.3928/00485713-20230515-01

João F. Pedrazzi, Lucas Hassib, F. R. Ferreira

{"title":"Therapeutic Profile of Cannabidiol in the Broad Symptomatology of Autism Spectrum Disorder: Evidence From Basic Science to Clinical Approaches","authors":"João F. Pedrazzi, Lucas Hassib, F. R. Ferreira","doi":"10.3928/00485713-20230515-01","DOIUrl":"https://doi.org/10.3928/00485713-20230515-01","url":null,"abstract":"\u0000 Autism spectrum disorder (ASD) is a group of neurodevelopmental disorders whose symptoms include impaired communication and social interaction, stereotypies, and varying levels of intellectual disability. Together with these symptoms are co-occurring psychiatric or neurological conditions, often with hyperactivity and attention disorders, anxiety, depression, and epilepsy. So far, no effective treatment for ASD is available, possibly because its neurobiological basis and heterogeneous nature are not clearly understood. Clinical and preclinical trials support the involvement of the endocannabinoid system in the patho-physiology of ASD. Cannabidiol (CBD), the main nonpsychotomimetic compound of the cannabis plant, interacts with the endocannabinoid system and has significant therapeutic potential in treating several psychiatric disorders and manifestations of ASD. After this article, readers are expected to have a broad understanding of current scientific evidence and perspectives on the use of CBD in cases of ASD.\u0000 \u0000 [\u0000 Psychiatr Ann\u0000 . 2023;53(6):247–251.]\u0000 \u0000","PeriodicalId":20917,"journal":{"name":"Psychiatric Annals","volume":" ","pages":""},"PeriodicalIF":0.5,"publicationDate":"2023-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"49281319","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Cannabidiol as a Treatment for Schizophrenia 大麻二酚治疗精神分裂症

4区医学

Psychiatric Annals Pub Date : 2023-06-01 DOI: 10.3928/00485713-20230505-01

João Roberto F. Lisboa, João Luís Simei, José Diogo R. de Souza, Felipe V. Gomes

引用次数: 0

An Overview of Diagnostic and Clinical Considerations Pertaining to Psychosis-Risk Syndromes 关于精神病危险综合征的诊断和临床考虑的概述

IF 0.5 4区医学

Psychiatric Annals Pub Date : 2023-05-01 DOI: 10.3928/00485713-20230417-01

Zachary B. Millman, M. Weintraub

{"title":"An Overview of Diagnostic and Clinical Considerations Pertaining to Psychosis-Risk Syndromes","authors":"Zachary B. Millman, M. Weintraub","doi":"10.3928/00485713-20230417-01","DOIUrl":"https://doi.org/10.3928/00485713-20230417-01","url":null,"abstract":"\u0000 Early intervention in psychosis can provide significant clinical benefits for patients, but disambiguating risk states from a full-threshold illness—a prerequisite for informed clinical decision-making—can be challenging. This article overviews the assessment, phenomenology, and treatment of clinical high-risk (CHR) syndromes, a set of risk factors and symptoms that indicate substantially elevated risk for psychosis when presenting among help-seeking youth. Symptoms associated with CHR states often present as qualitatively similar to those of formal psychotic disorders and may be associated with distress and behavior change. However, insight has not been lost and behavior is not seriously disorganized or dangerous. The emerging nature of these symptoms in conjunction with the young age of patients at CHR and high levels of public stigma bring unique challenges to assessment, clinical feedback, and treatment. Nonetheless, there are numerous guidelines and standards that can support clinicians in providing high quality care for this important population.\u0000 \u0000 [\u0000 Psychiatr Ann\u0000 . 2023;53(5):194–198.]\u0000 \u0000","PeriodicalId":20917,"journal":{"name":"Psychiatric Annals","volume":" ","pages":""},"PeriodicalIF":0.5,"publicationDate":"2023-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"43351465","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Differential Diagnosis of Trauma Spectrum Disorders and Clinical High Risk for Psychosis 创伤谱系障碍与精神病临床高危人群的鉴别诊断

IF 0.5 4区医学

Psychiatric Annals Pub Date : 2023-05-01 DOI: 10.3928/00485713-20230414-01

Tamara Welikson, P. E. Guvenek-Cokol

引用次数: 0

Autism Spectrum Disorder and Schizophrenia Spectrum Disorders 自闭症谱系障碍和精神分裂症谱系障碍

IF 0.5 4区医学

Psychiatric Annals Pub Date : 2023-05-01 DOI: 10.3928/00485713-20230424-01

Hyun Jung Kim, E. Carol

引用次数: 1